Levin M and Mercola M |
Expression of connexin 30 in Xenopus embryos and its involvement in hatching gland function. |
2000 |
Dev. Dyn. |
pmid:10974676
|
Harris J et al. |
Spinal anandamide inhibits nociceptive transmission via cannabinoid receptor activation in vivo. |
2000 |
Neuroreport |
pmid:10976969
|
Oz M et al. |
Endogenous cannabinoid anandamide directly inhibits voltage-dependent Ca(2+) fluxes in rabbit T-tubule membranes. |
2000 |
Eur. J. Pharmacol. |
pmid:10980258
|
Wiley JL et al. |
Influence of phenylmethylsulfonyl fluoride on anandamide brain levels and pharmacological effects. |
2000 |
Life Sci. |
pmid:10983852
|
Stefano GB et al. |
2-arachidonyl-glycerol stimulates nitric oxide release from human immune and vascular tissues and invertebrate immunocytes by cannabinoid receptor 1. |
2000 |
Pharmacol. Res. |
pmid:10987990
|
Klein TW et al. |
The cannabinoid system and cytokine network. |
2000 |
Proc. Soc. Exp. Biol. Med. |
pmid:10998193
|
Szallasi A and Di Marzo V |
New perspectives on enigmatic vanilloid receptors. |
2000 |
Trends Neurosci. |
pmid:11006466
|
Fernandez-Patron C et al. |
Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction. |
2000 |
Circ. Res. |
pmid:11029402
|
De Petrocellis L et al. |
Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity. |
2000 |
FEBS Lett. |
pmid:11033355
|
Di Marzo V et al. |
Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide. |
2000 |
Eur. J. Pharmacol. |
pmid:11040343
|
Bisogno T et al. |
N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo. |
2000 |
Biochem. J. |
pmid:11042139
|
Di Marzo V et al. |
Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain. |
2000 |
J. Neurochem. |
pmid:11080195
|
Rubino T et al. |
Loss of cannabinoid-stimulated guanosine 5'-O-(3-[(35)S]Thiotriphosphate) binding without receptor down-regulation in brain regions of anandamide-tolerant rats. |
2000 |
J. Neurochem. |
pmid:11080200
|
Giuffrida A et al. |
Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404. |
2000 |
Eur. J. Pharmacol. |
pmid:11080522
|
Calignano A et al. |
Bidirectional control of airway responsiveness by endogenous cannabinoids. |
2000 |
Nature |
pmid:11081515
|
Maccarrone M et al. |
Anandamide and 2-arachidonoylglycerol inhibit fatty acid amide hydrolase by activating the lipoxygenase pathway of the arachidonate cascade. |
2000 |
Biochem. Biophys. Res. Commun. |
pmid:11095952
|
Calignano A et al. |
A role for the endogenous cannabinoid system in the peripheral control of pain initiation. |
2000 |
Prog. Brain Res. |
pmid:11098711
|
Reggio PH and Traore H |
Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase. |
2000 |
Chem. Phys. Lipids |
pmid:11106780
|
Howlett AC and Mukhopadhyay S |
Cellular signal transduction by anandamide and 2-arachidonoylglycerol. |
2000 |
Chem. Phys. Lipids |
pmid:11106782
|
Schmid HH |
Pathways and mechanisms of N-acylethanolamine biosynthesis: can anandamide be generated selectively? |
2000 |
Chem. Phys. Lipids |
pmid:11106783
|